NSE
Artemis Medicare Services LimitedARTEMISMED
Artemis Medicare Services Limited is a healthcare services company focused on providing medical solutions in India.
| Key products | Medical diagnostic services, telemedicine platforms |
|---|---|
| Geography | India |
| Competitors | Apollo Hospitals Enterprises Ltd., Max Healthcare Ltd. |
AI-generated overview β verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 Β· tilt Neutral
Next corporate action
Dividend - Re 0.45 Per Share
ex 2025-07-11
| # | Company | Inst. flow βΉCr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +βΉ41.3 Cr | 331 | β | β | β | β |
| 2 | ATALREAL | +βΉ7 Cr | 367 | β | β | β | β |
| 3 | GATECH | +βΉ0.4 Cr | 298 | β | β | β | β |
| 4 | ARTEMISMEDThis | β | β | β | β | β | β |
| 5 | IRMENERGY | ββΉ2.2 Cr | 356 | β | β | β | β |
| 6 | QUADFUTURE | ββΉ9 Cr | 581 | β | β | β | β |
| 7 | MOBIKWIK | ββΉ150.9 Cr | 975 | β | β | β | β |
Ranked by net institutional flow (buys β sells, βΉCr). Filing momentum = bullish β bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Strengths
- β’ [object Object]
- β’ [object Object]
Weaknesses
- β’ Limited geographic reach compared to larger competitors
- β’ Dependence on government initiatives for growth
Opportunities
- β’ Growing demand for telemedicine services in India
Threats
- β’ [object Object]
AI-generated from our data β verify before relying on it.
- 2026-06-16FilingArtemis Medicare Services Limited has informed the Exchange about schedule of the Hospital Visit by Investors/Investor Call
- 2026-06-12FilingOnkar KanwarΒ has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and EShareholding Disclosure
- 2025-07-11ActionDividend - Re 0.45 Per ShareDividend
- 2024-07-05ActionDividend - Rs 0.45 Per ShareDividend
Merged from deals, filings, corporate actions and news β newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 3Investor CallNeutral
schedule of the Hospital Visit by Investors/ Analysts - June 19, 2026
Source PDF β - 2Shareholding DisclosureNeutral
a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Source PDF β
No bulk/block deals for ARTEMISMED in this window.
Results & transcripts
Financial results
None yet.
News & chatter on ARTEMISMED
RSS News
0No recent news.
Google News RSS β links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.